News Archive

Cleveland is home to more than 700 bioscience companies, a powerful ecosystem that draws strength from a clinical, research and educational foundation dedicated to growth and medical innovation. A new rebranding initiative led by a host of area institutions is ready to send this message out into the world.

Called “The Medical Capital,” the campaign’s centerpiece is a website where visitors can access information regarding biomedical investments and start-up activity in the region. Organizers are also offering a video showcasing the region’s burgeoning tech-based assets, complete with testimonials from investors and CEOs. Social media is another facet of the effort.

Mitre and the University System of Maryland have selected five U.S. academic professionals as recipients of $293,000 in seed grants to conduct studies on cybersecurity challenges, ExecutiveBiz reported Friday.

The company said Thursday the grants went to researchers from George Mason University, University of Maryland in Baltimore, University of Maryland in College Park, University of Texas at San Antonio and University of Alabama at Birmingham.

Roche is rumored to make a move on the California biotech BioMarin. Despite a slightly weakened pipeline, Roche appears undeterred and previous offers were predicted to be around $15Bn.

As big as some of the other industry veterans, BioMarin was founded in the 90’s boom in Biotech in San Rafaele, California. The deal itself is entirely based on rumor and anonymous sources, originally appearing on the blog Betaville.

This is the fifth consecutive year for the USA Creative Business Cup. This year for the first time there will be a f2f finals for competing teams in Washington, DC as part of the activities of Creative World – DC (creativeworld.group) and the National Creativity Network Conference within it. The USA national winner goes on to compete for the 2016 global Creative Business Cup in Copenhagen, Denmark (November 20-21) as a featured event of the 2016 Global Entrepreneurship Week (GEW). It is anticipated that over 60 nations will send teams to compete in this year’s event.

When: July 28th 5:00 p.m. to 7:00 p.m.

Where: BRI 9410 Key West Ave Rockville, MD 20850

Join BioBuzz and July Co-Sponsors BRI and Azzur IT, as we visit BRI’s offices and labs at their new location in Rockville on July 28th. Biomedical Research Institute (BRI), a 501 c 3 non-profit company, which focuses on the development of diagnostic and vaccine solutions to Schistosomiasis, a parasitic disease that impacts sub-Saharan Africa, Brazil and rural Asia where 800 million people live and over 200 million people are infected.

The expanding role of healthcare providers is not limited to societies with “developed” healthcare systems. Diseases, such as AIDS and malaria, prevalent in the third world and emerging countries are now considered chronic or curable with the proper treatment, leaving those afflicted with greater chance of recovery. However, as the cost the typical person pays for healthcare over his or her lifetime rises, the question becomes: How will these emerging societies, especially those in less-developed countries, sustain a rising bill?

After months of work under the radar, GlaxoSmithKline committed to entering the Zika R&D field, announcing on Thursday that it’s pairing with the National Institutes of Health in a project based at its new vaccine research hub in Rockville, MD.

At the first annual meeting for MCEDC, the Executive Committee is re-elected, the newly appointed Interim Director is announced, and the FY2017 budget is set.

The Montgomery County Economic Development Corporation (MCEDC) held its first annual meeting on June 13, 2016, at which it re-elected their Executive Committee for the coming year. As of July 1, 2016, MCEDC replaced both the Montgomery County Department of Economic Development (MCDED) and the Montgomery Business Development Corporation (MBDC); both entities are now officially dissolved. MCEDC is now the primary point of contact for the local, regional, national and international business community.

Canada’s publicly funded health care system is a source of pride and a defining value for Canadians. They rely on it for timely access to universal, high-quality and innovative treatments and services that are based on need, not on the ability to pay. To support Canadians battling cancer, the Government of Canada is investing $15 million over five years in the Centre for Commercialization of Cancer Immunotherapy (C3i). Immunotherapy is an emerging area of medicine that uses the power of the immune system to combat cancer. When brought to market, C3i’s form of cancer treatment stands to revolutionize cancer care by providing access to non-toxic, highly efficient cures that do not rely on chemotherapy.

Following in their Senate colleagues’ footsteps, a House subcommittee signed off on a budget increase for the National Institutes of Health Thursday. The increases for fiscal-year 2017 confirm lawmakers’ public pledges to establish a pattern of improved budgets for the agency, which before last year saw more than a decade of flat funding.